Evotec SE (EVO)
NASDAQ: EVO · IEX Real-Time Price · USD
4.700
-0.080 (-1.67%)
At close: Jul 19, 2024, 4:00 PM
4.760
+0.060 (1.28%)
Pre-market: Jul 22, 2024, 4:00 AM EDT
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.67 billion as of July 22, 2024. Its market cap has decreased by -57.57% in one year.
Market Cap
1.67B
Enterprise Value
1.63B
1-Year Change
-57.57%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since the IPO on February 5, 2015, Evotec SE's market cap has increased from $464.70M to $1.67B, an increase of 258.65%. That is a compound annual growth rate of 14.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.67B | -59.93% |
| Dec 29, 2023 | 4.16B | 45.19% |
| Dec 30, 2022 | 2.86B | -65.68% |
| Dec 31, 2021 | 8.34B | 108.85% |
| Dec 31, 2020 | 3.99B | 42.78% |
| Dec 31, 2019 | 2.80B | 29.06% |
| Dec 31, 2018 | 2.17B | 24.07% |
| Dec 29, 2017 | 1.75B | 106.15% |
| Dec 30, 2016 | 847.40M | 72.48% |
| Dec 31, 2015 | 491.30M | 5.72% |
| Feb 5, 2015 | 464.70M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 1.77B |
| Keros Therapeutics | 1.75B |
| Galapagos NV | 1.72B |
| Soleno Therapeutics | 1.71B |
| NewAmsterdam Pharma Company | 1.70B |
| Supernus Pharmaceuticals | 1.66B |
| Kura Oncology | 1.60B |
| Avadel Pharmaceuticals | 1.56B |